Gilead Sciences

Q1 2026 in 28d Q4 2025 Q3 2025 +3.11%Q2 2025 +8.17%Q1 2025 -2.81%Q4 2024 +7.46%Q3 2024 +8.51%Q2 2024 -0.46%Q1 2024 -2.47%Q4 2023 -2.99%Q3 2023 -3.99%Q2 2023 +3.96%Q1 2023 -1.83%Q4 2022 +0.60%Q3 2022 +11.93%Q2 2022 +4.48%Q1 2022 -3.65%Q4 2021 -4.16%Q3 2021 -2.83%Q2 2021 -2.53%Q1 2021 -1.51%Q4 2020 +6.11%Q3 2020 -2.47%Q2 2020 -4.77%Q1 2020 -3.84%Q4 2019 -0.74%Q3 2019 -4.90%Q2 2019 -3.46%Q1 2019 +3.48%Q4 2018 -3.38%Q3 2018 +2.54%Q2 2018 +0.66%Q1 2018 -7.41%Q4 2017 +5.60%Q3 2017 -3.53%Q2 2017 +1.65%Q1 2017 -1.32%Q4 2016 -7.68%Q3 2016 -1.52%Q2 2016 -6.35%Q1 2016 -12.42%Q4 2015 +2.78%Q3 2015 -0.46%Q2 2015 +4.68%Q1 2015 +2.63%Q4 2014 -7.31%Q3 2014 -1.66%Q2 2014 +1.35%Q1 2014 +3.16%Q4 2013 -0.86%Q3 2013 +5.73%Q2 2013 +4.49%Q1 2013 +9.99%Q4 2012 -0.05%Q3 2012 +2.95%Q2 2012 +8.40%Q1 2012 -0.80%Q4 2011 +1.62%Q3 2011 +0.39%Q2 2011 -1.60%Q1 2011 +0.38%Q4 2010 -1.13%Q3 2010 -1.18%Q2 2010 -0.11%Q1 2009 +2.35%Q1 2010 +0.04%Q4 2007 -0.17%Q4 2009 -0.17%Q3 2008 +5.42%Q3 2009 +5.42%Q2 2008 -4.97%Q2 2009 -4.97%Q4 2008 -4.97%

May 02, 2019

•

Mar 31, 2019

Gilead Sciences Q1 2019 Earnings Report

Total Revenue

$5.28B

Previous year: $5.09B

Previous year: $4.09B

+5.8%

Cash and Equivalents

$16.9B

Previous year: $7.64B

+121.5%

Free Cash Flow

$1.34B

Previous year: $2.06B

-34.9%

Total Assets

$62.8B

Previous year: $65.4B

-3.9%

Gilead Sciences

Unlock previous datapoints

Upgrade

Gilead Sciences

Unlock previous datapoints

Upgrade

Revenue by Segment

HIV Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Oncology Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue by Geographic Location

United States Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Europe Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Rest of World Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Gilead Sciences

Products

Get in Touch

Resources

Gilead Sciences

Gilead Sciences Q1 2019 Earnings Report

Gilead Sciences

Gilead Sciences

Revenue by Segment

HIV Revenue

Oncology Revenue

Revenue by Geographic Location

United States Revenue

Europe Revenue

Rest of World Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Gilead Sciences Revenue by Segment

Gilead Sciences Revenue by Geographic Location